scispace - formally typeset
A

Ad R. M. M. Hermus

Researcher at Radboud University Nijmegen

Publications -  200
Citations -  10101

Ad R. M. M. Hermus is an academic researcher from Radboud University Nijmegen. The author has contributed to research in topics: Congenital adrenal hyperplasia & Population. The author has an hindex of 53, co-authored 199 publications receiving 8971 citations. Previous affiliations of Ad R. M. M. Hermus include Radboud University Nijmegen Medical Centre.

Papers
More filters
Journal ArticleDOI

Systematic Review: Diagnostic Procedures to Differentiate Unilateral From Bilateral Adrenal Abnormality in Primary Aldosteronism

TL;DR: A recent prospective study of 203 patients showed that operative planning based on anatomical imaging alone would have inappropriately excluded 21.7% of patients from adrenalectomy and would have led to unnecessary sugery in 24.7%.
Journal ArticleDOI

High prevalence of testicular adrenal rest tumors, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia.

TL;DR: Testicular adrenal rest tumors are frequently present in adolescent and adult males with congenital adrenal hyperplasia and are often accompanied by impaired spermatogenesis and Leydig cell failure.
Journal ArticleDOI

Thyroid Function and Prevalence of Anti-Thyroperoxidase Antibodies in a Population with Borderline Sufficient Iodine Intake: Influences of Age and Sex

TL;DR: In inhabitants of the eastern part of The Netherlands, serum TSH gradually decreases with age, whereas after age 60, serum FT4 increases, possibly because of the development of thyroid autonomy after longstanding borderline sufficient iodine intake.
Journal ArticleDOI

A systematic review and meta-analysis on the effects of exercise training versus hypocaloric diet: distinct effects on body weight and visceral adipose tissue.

TL;DR: Despite a larger effect of diet on total body weight loss, exercise tends to have superior effects in reducing VAT and may represent a poor marker when evaluating benefits of lifestyle‐interventions.